Research and practice about risk control of shenfu injection.
- Author:
Zhi-Fei WANG
;
Da-Li TIAN
;
Wen ZHANG
;
Yan-Ming XIE
- Publication Type:Journal Article
- MeSH:
Drugs, Chinese Herbal;
administration & dosage;
adverse effects;
Humans;
Injections;
Medicine, Chinese Traditional;
methods
- From:
China Journal of Chinese Materia Medica
2014;39(18):3641-3644
- CountryChina
- Language:Chinese
-
Abstract:
Shenfu injection is developed by improving dosage form of ancient prescription "Shenfu Tang" and is mainly derived from extracts of both traditional Chinese medicine red ginseng and prepared lateral root of monkshood with polysorbate 80 as auxiliary material. Shenfu injection may be administered through intramuscular injection, intravenous drip or intravenous injection. It produces good effects in restoring Yang and rescuing patients from collapse, tonifying Qi and preventing exhaustion. It is mainly used to treat not only syncope and prostration resulting from sudden Yang collapse (infectious, hemorrhagic and water depletion shock etc), but also pavor, palpitation, dyspnea with cough, stomachache, diarrhea and arthralgia etc caused by deficiency of Yang (deficiency of vital energy). Research group has audited the monitored hospitals and has carried out postmarketing study of Shenfu solution from many aspects including literature review, spontaneous reporting system (SRS) and hospital information system (HIS) data analysis etc. A summary is shown below.
